Article

Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells

National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, Arkansas 72079, USA.
ACS Nano (Impact Factor: 12.03). 08/2011; 5(9):7020-33. DOI: 10.1021/nn2016259
Source: PubMed

ABSTRACT We investigated and compared the concentration-dependent cytotoxicity of single-walled carbon nanotubes (SWCNTs) and SWCNTs functionalized with polyethylene glycol (SWCNT-PEGs) in neuronal PC12 cells at the biochemical, cellular, and gene expressional levels. SWCNTs elicited cytotoxicity in a concentration-dependent manner, and SWCNT-PEGs exhibited less cytotoxic potency than uncoated SWCNTs. Reactive oxygen species (ROS) were generated in both a concentration- and surface coating-dependent manner after exposure to these nanomaterials, indicating different oxidative stress mechanisms. More specifically, gene expression analysis showed that the genes involved in oxidoreductases and antioxidant activity, nucleic acid or lipid metabolism, and mitochondria dysfunction were highly represented. Interestingly, alteration of the genes is also surface coating-dependent with a good correlation with the biochemical data. These findings suggest that surface functionalization of SWCNTs decreases ROS-mediated toxicological response in vitro.

Download full-text

Full-text

Available from: Susan Lantz-McPeak, Jun 27, 2014
1 Follower
 · 
292 Views
  • Source
    • "The cRM has been applied as a fast and label-free analytical approach to detect carbon-based nanomaterials in biological system [60]. GNMs' use as an agent for SERS has attracted much attention in recent years [61]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Plasmonic nanomaterials as drug delivery or bio-imaging agents are typically introduced to biological systems through intravenous administration. However, the potential for agglomeration of nanoparticles in biological systems could dramatically affect their pharmacokinetic profile and toxic potential. Development of rapid screening methods to evaluate agglomeration is urgently needed to monitor the physical nature of nanoparticles as they are introduced into blood. Here, we establish novel methods using darkfield microscopy with hyperspectral detection (hsDFM), single particle inductively-coupled plasma mass spectrometry (spICP-MS), and confocal Raman microscopy (cRM) to discriminate gold nanoparticles (AuNPs) and their agglomerates in blood. Rich information about nanoparticle agglomeration in situ is provided by hsDFM monitoring of the plasmon resonance of primary nanoparticles and their agglomerates in whole blood; cRM is an effective complement to hsDFM to detect AuNP agglomerates in minimally manipulated samples. The AuNPs and the particle agglomerates were further distinguished in blood for the first time by quantification of particle mass using spICP-MS with excellent sensitivity and specificity. Furthermore, the agglomeration status of synthesized and commercial NPs incubated in blood was successfully assessed using the developed methods. Together, these complementary methods enable rapid determination of the agglomeration status of plasmonic nanomaterials in biological systems, specifically blood. Published by Elsevier Ltd.
    Biomaterials 05/2015; 51. DOI:10.1016/j.biomaterials.2015.01.072 · 8.31 Impact Factor
  • Source
    • "We also analyzed the GSH content, as GSH is a major intracellular low-molecular-weight thiol compound that plays a critical role in the cellular defense against oxidative stress through scavenging of ROS directly or indirectly in cells (Halliwell and Gutteridge, 2001), and GCL activity , as GCL is the enzyme responsible for catalyzing the synthesis of GSH (Maher, 2006). Our results indicated a significant decrease in the GSH content of the extract exposed to lower concentrations of SWNT- PEG (Fig. 4), a finding that agreed with the results of other studies (Zhang et al., 2011; Valko et al., 2007). The depletion of GSH content induced by SWNT-PEG may be due to an increased production of reactive oxygen species (ROS). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology has been proven to be increasingly compatible with pharmacological and biomedical applications. Therefore, we evaluated the biological interactions of single-wall carbon nanotubes functionalized with polyethylene glycol (SWNT- PEG). For this purpose, we analyzed biochemical, histological, behavioral and biodistribution parameters to understand how this material behaves in vitro and in vivo using the fish Danio rerio (zebrafish) as a biological model. The in vitro results for fish brain homogenates indicated that SWNT-PEG had no effect on lipid peroxidation, total antioxidant capacity, GSH (reduced glutathione) levels or GCL (glutathione-cysteine ligase) activity. However, after intraperitoneal exposure, SWNT-PEG proved to be less biocompatible and formed aggregates, suggesting that the PEG used for the nanoparticle functionalization was of an inappropriate size for maintaining product stability in a biological environment. This problem with functionalization may have contributed to the low or practically absent biodistribution of SWNT-PEG in zebrafish tissues, as verified by Raman spectroscopy. There was an accumulation of material in the abdominal cavity that led to inflammation and behavioral disturbances, as evaluated by a histological analysis and an open field test, respectively. These results provide evidence of a lack of biocompatibility of SWNTs modified with short chain PEGs, which leads to the accumulation of the material, tissue damage and behavioral alterations in the tested subjects.
    Toxicology and Applied Pharmacology 08/2014; 280(3). DOI:10.1016/j.taap.2014.08.018 · 3.63 Impact Factor
  • Source
    • "Also, the coating of the nanotubes by DNA, reduced their toxic properties. It was recently proved that by PEG-coating single walled carbon nanotubes, their in vitro genotoxicity and cytotoxicity was decreased significantly (Zhang et al., 2011). The use of unprocessed CNTs would probably not be used as the major component in novel bio-medical applications, due to their immediate clustering, which would make them prone to embolisms or other undesired effects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multi-walled carbon nanotubes (MWCNTs) are widely used for nanotechnology. Their impact on living organisms is, however, not entirely clarified. Oxidative stress and inflammation seem to be the key mechanisms involved in MWCNTs' cytotoxicity. Until present, pulmonary and skin models were the main tested experimental designs to assess carbon nanotubes' toxicity. The systemic administration of MWCNTs is essential, with respect for future medical applications. Our research is performed on Wistar rats and is focused on the dynamics of oxidative stress parameters in blood and liver and pro-inflammatory cytokines in liver, after single dose (270mgl(-1)) ip administration of MWCNTs (exterior diameter 15-25nm, interior diameter 10-15nm, surface 88m(2)g(-1)) functionalized with single strand DNA (ss-DNA). The presence of MWCNTs in blood was assessed by Raman spectroscopy, while in liver histological examination and confocal microscopy were used. It was found that ss-DNA-MWCNTs induce oxidative stress in plasma and liver, with the return of the tested parameters to normal values, 6h after ip injection of nanotubes, with the exception of reduced glutathione in plasma. The inflammatory cytokines (TNF-α, IL-1β) had a similar pattern of evolution. We also assessed the level of ERK1/2 and the phosphorylation of p65 subunit of NF-kB in liver that had a transient increase and returned to normal at the end of the tested period. Our results demonstrate that ss-DNA-MWCNTs produce oxidative stress and inflammation, but with a transient pattern. Given the fact that antioxidants modify the profile not only for oxidative stress, but also of inflammation, the dynamics of these alterations may be of practical importance for future protective strategies.
    Toxicology and Applied Pharmacology 01/2012; 259(3):281-92. DOI:10.1016/j.taap.2012.01.004 · 3.63 Impact Factor
Show more